健亞生物科技股份有限公司 Approved
最後更新時間 2025/07/13 , 02:43 AM
最後更新時間 2025/07/13 , 02:43 AM
負責人
Chen,Zheng
統一編號
84149006
成立日期
1993/03/24
資本額
NT$2,500,000,000
實收資本額
NT$1,126,571,270
股票代號
4130
電話
03-5982221
地址
No. 1, Gongye 1st Rd., Zhongxing Vil., Hukou Township, Hsinchu County, 303, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Chen,Zheng Chairman 0.20%
Chen,Tou-Hui Director 26.72% NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN
Huang,Qi-Ying Director 26.72% NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN
Zhu,Jia-Zhen Director 0.10%
Zhang,Jin-Ming Independent Director 0.00%
Li,Shi-Ren Independent Director 0.00%
Liu,Ke-Yi Independent Director 0.00%
Su,Lai-Shou Independent Director
營業項目
  • Manufacture of Medicinal Biological Products(200300)
  • Manufacture of Drugs and Medicines(200211)
  • Wholesale on a Fee or Contract Basis(451099)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Person in Charge to Chen,Zheng
    2015/11/24
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 131,306 510,856 528,512
    Operating cost 84,003 318,207 317,596
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 47,303 192,649 210,916
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 47,303 192,649 210,916
    Operating expenses 37,301 169,219 183,909
    Other gain (loss), net - - -
    Operating profit (loss) 10,002 23,430 27,007
    Non-operating income and expenses 2,302 7,630 3,818
    Net profit (loss) before tax 12,304 31,060 30,825
    Income tax expense (benefits) 2,759 5,362 1,491
    Net profit (loss) of ongoing business for the current period 9,545 25,698 29,334
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 9,545 25,698 29,334
    Other comprehensive profit (loss), net -17,531 -3,314 47,706
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -7,986 22,384 77,040
    Net profit (loss) attributable to owners of parent company 9,545 25,698 29,334
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company -7,986 22,384 77,040
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 0 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 41,224 55,112 84,782
    Net cash inflows (outflows) from investing activities -68,268 29,641 -78,683
    Net cash inflow (outflow) from financing activities -209 -43,183 -20,232
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period -27,253 41,570 -14,133
    Beginning balance of cash and cash equivalents 221,602 180,032 194,165
    Ending balance of cash and cash equivalents 194,349 221,602 180,032
    項目 2025 2024 2023
    Current asset 745,609 765,452 771,772
    Non-current asset 844,655 824,762 828,684
    Total asset 1,590,264 1,590,214 1,600,456
    Current liability 155,931 136,480 117,726
    Non-current liability 4,333 4,596 13,960
    Total liability 160,264 141,076 131,686
    share capital 1,126,571 1,126,571 1,093,758
    Equity - secruity token - - -
    capital reserve 210,664 210,664 210,556
    retained earning 148,070 152,629 177,794
    Other equity -29,587 -15,008 -13,338
    Treasury stock -25,718 -25,718 0
    Total equity attributable to owners of parent company 1,430,000 1,449,138 1,468,770
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 1,430,000 1,449,138 1,468,770
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 1,137,000 1,137,000 0
    Net asset value per share 12 12 13
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • MMF
  • GranPatch
  • Granpatch
  • Diachrome
  • 護糖
  • 銀安
  • Nutrition21
  • EnVie
  • 蠍子圖
  • Genovate
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2005, 2006, 2007
  • Return security deposit
    2006
  • Exclude infringement, etc.
    2006
  • Infringement of patent rights related to property rights disputes, etc.
    2013, 2014
  • Others
    2008, 2012, 2013
  • Pay for the goods
    2007
  • Invalidating Judgment
    2010
  • Compensation for damage
    2009
  • Petition filed for public summons
    2009
  • Fair Trading Act damage compensation, etc.
    2010
  • Infringement of patent rights related to property rights disputes, etc.
    2013, 2014
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。